A Phase I/II Study of Cyclophosphamide and Topotecan in Patients with High-Risk Malignancies Undergoing Autologous Hematopoietic Cell Transplantation: The St. Jude Long-term Follow-up

Fifty-eight consecutive children with high-risk malignancies were treated with cyclophosphamide and targeted topotecan followed by autologous hematopoietic cell transplantation (AHCT) in a phase I/II IRB-approved study. Twelve participants enrolled in phase I; 5 received dose level 1 of topotecan 3m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Main Authors: Kasow, Kimberly A., Stewart, Clinton F., Barfield, Raymond C., Wright, Nancy L., Li, Chenghong, Srivastava, Deo Kumar, Leung, Wing, Horwitz, Edwin M., Bowman, Laura C., Handgretinger, Rupert, Hale, Gregory A.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4893814/
https://ncbi.nlm.nih.gov/pubmed/22426752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2012.51
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares